Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.57 |
| ▸ | CES1 | P23141 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoyl Peroxide SCHEMBL6003528 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| Benzoyl Peroxide SCHEMBL28087289 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL2149394 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL5561553 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL2149475 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| Benzoyl Peroxide SCHEMBL3684199 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL1162208 | 1.00 | CES2 (0.57) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL28543800 | 0.98 | CES2 (0.55) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL11272035 | 0.98 | CES2 (0.55) | CES2CES1LMNAF2ASAH1 | |
| SCHEMBL10404682 | 0.98 | LMNA (0.57) | CES2CES1LMNAF2ASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565561-A1 | METHOD FOR PREPARING A COMPOSITION IN POWDER FORM COMPRISING AT LEAST ONE SOLID ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2025-06-11 | — | — | EP | disclosed |
| CN-119604485-A | Composition comprising at least one solid organic peroxide | 阿科玛法国公司 | 2025-03-11 | — | — | CN | disclosed |
| WO-2024028229-A1 | METHOD FOR PREPARING A COMPOSITION IN POWDER FORM COMPRISING AT LEAST ONE SOLID ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2024-02-08 | — | — | WO | disclosed |
| WO-2024023460-A1 | COMPOSITION COMPRISING AT LEAST ONE SOLID ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2024-02-01 | — | — | WO | disclosed |
| EP-4034576-A1 | SOLID ANHYDROUS COMPOSITION IN POWDER FORM COMPRISING AT LEAST ONE ORGANIC PEROXIDE, AT LEAST ONE PHLEGMATIZING AGENT AND AT LEAST ONE BINDER AND CORRESPONDING PREPARATION METHOD | ARKEMA FRANCE (FR) | 2022-08-03 | — | — | EP | disclosed |
| WO-2021058926-A1 | SOLID ANHYDROUS COMPOSITION IN POWDER FORM COMPRISING AT LEAST ONE ORGANIC PEROXIDE, AT LEAST ONE PHLEGMATIZING AGENT AND AT LEAST ONE BINDER AND CORRESPONDING PREPARATION METHOD | ARKEMA FRANCE (FR) | 2021-04-01 | — | — | WO | disclosed |
| EP-2061524-A2 | COLOR CHANGING SKIN SEALANT | Kimberly-Clark Worldwide, Inc. (US) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008032231-A2 | COLOR CHANGING SKIN SEALANT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| US-20080063615-A1 | Color changing skin sealant | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-03-13 | — | — | US | disclosed |
| EP-1159014-B1 | ARTICLES COMPRISING OXIDISING AND HEMOLYTIC AGENTS | PROCTER & GAMBLE (US) | 2007-04-18 | — | — | EP | disclosed |
| EP-1034800-A1 | Articles having an odour control system comprising an oxidising agent and an odour absorbing agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034803-A1 | Breathable absorbent articles having an oxidising agent based odour control system | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034804-A1 | Articles comprising an oxidising agent and a hemolytic agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034801-A1 | Absorbent articles having an odour control system comprising an oxidising agent and a chelating agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| WO-2000051652-A1 | ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051651-A1 | ABSORBENT ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051654-A1 | ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051656-A1 | BREATHABLE ABSORBENT ARTICLES HAVING AN OXIDISING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051655-A1 | ARTICLES COMPRISING OXIDISING AND HEMOLYTIC AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| US-4363322-A | Deodorizing and disinfecting liquid-absorbing product and process for production thereof | ANDERSSON A E BROR | 1982-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080063615-A1 | Color changing skin sealant | CUTA, PROC, RBP1 | CES2 847/4885CES1 1791/4885LMNA 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.